⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60772 | 0.78 | — | — | |
| SCHEMBL28566412 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL28638294 | 0.74 | — | — | |
| SCHEMBL3161687 | 0.73 | — | — | |
| SCHEMBL4475934 | 0.72 | LMNA (0.62) | — | |
| SCHEMBL7743262 | 0.72 | — | — | |
| SCHEMBL52275 | 0.72 | — | — | |
| SCHEMBL1668284 | 0.72 | — | — | |
| Bicarbonate SCHEMBL8812310 | 0.70 | — | — | |
| Water SCHEMBL23118545 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022240255-A1 | BIODEGRADABLE STENT AND MANUFACTURING METHOD THEREFOR | 전남대학교산학협력단 | 2022-11-17 | — | — | WO | claimed |
| WO-2021238893-A1 | EFFICIENT AND EFFECTIVE TISSUE CLEARING AGENTS AND THEIR COMPOSITIONS | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2021-12-02 | — | — | WO | claimed |
| US-20170066828-A1 | Humanized Anti-HLA-DR Antibodies | IMMUNOMEDICS, INC. | 2017-03-09 | — | — | US | claimed |
| US-9393325-B2 | Bioabsorbable co-filler for cerebrovascular aneurysms | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2016-07-19 | — | — | US | claimed |
| US-20160151124-A1 | IMPLANTABLE MARKERS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-06-02 | — | — | US | claimed |
| EP-3019208-A1 | IMPLANTABLE MARKERS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2016-05-18 | — | — | EP | claimed |
| EP-1521775-B1 | MONOCLONAL ANTIBODY PAM4 AND ITS USE FOR DIAGNOSIS AND THERAPY OF PANCREATIC CANCER | IMMUNOMEDICS INC (US) | 2015-09-09 | — | — | EP | claimed |
| US-8986699-B2 | Anti-CD74 immunoconjugates and methods of use | IMMUNOMEDICS, INC. (US) | 2015-03-24 | — | — | US | claimed |
| WO-2015004669-A1 | IMPLANTABLE MARKERS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-01-15 | — | — | WO | claimed |
| EP-1519958-B1 | HUMANIZED MONOCLONAL ANTIBODY HPAM4 | IMMUNOMEDICS INC (US) | 2014-10-15 | — | — | EP | claimed |
| WO-2003103723-A2 | NEUTROPHIL IMAGING METHODS IN CYCTIC FIBROSIS | IMMUNOMEDICS, INC. (US) | 2003-12-18 | — | — | WO | claimed |
| WO-2003097105-A1 | DRUG PRE-TARGETING BY MEANS OF BI-SPECIFIC ANTIBODIES AND HAPTEN CONSTRUCTS COMPRISING A CARRIER PEPTIDE AND THE ACTIVE AGENT (S) | IMMUNOMEDICS, INC. (US) | 2003-11-27 | — | — | WO | claimed |
| US-20030198595-A1 | Use of bi-specific antibodies for pre-targeting diagnosis and therapy | IMMUNOMEDICS, INC. | 2003-10-23 | — | — | US | claimed |
| US-20030148409-A1 | Direct targeting binding proteins | IBC PHARMACEUTICALS | 2003-08-07 | — | — | US | claimed |
| WO-2003033654-A2 | DIRECT TARGETING BINDING PROTEINS | IMMUNOMEDICS, INC (US) | 2003-04-24 | — | — | WO | claimed |
| WO-2002082041-A2 | PRODUCTION AND USE OF NOVEL PEPTIDE-BASED AGENTS FOR USE WITH BI-SPECIFIC ANTIBODIES | IMMUNOMEDICS, INC. (US) | 2002-10-17 | — | — | WO | claimed |
| EP-0703790-B1 | IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS | BRACCO SPA (IT) | 2000-08-16 | — | — | EP | claimed |
| US-5660814-A | Iodinated paramagnetic chelates, and their use as contrast agents | DIBRA S.P.A. (IT) | 1997-08-26 | — | — | US | claimed |
| EP-0703790-A1 | IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS | BRACCO S.p.A. (IT) | 1996-04-03 | — | — | EP | claimed |
| WO-1994027644-A1 | IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS | BRACCO S.P.A. (IT) | 1994-12-08 | — | — | WO | claimed |